QT
LGND icon

Quantbot Technologies’s Ligand Pharmaceuticals LGND Stock Holding History

Quantbot Technologies’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,644
Closed -$878K – 1966
2025
Q4 		$878K Buy
+4,644
New +$892K 0.03% 726
2023
Q1 		– Sell
-1,421
Closed -$94.9K – 1829
2022
Q4 		$94.9K Buy
+1,421
New +$92.4K 0.01% 1140
2022
Q1 		– Sell
-147
Closed -$14K – 1871
2021
Q4 		$14K Buy
147
+96
+188% +$8.87K ﹤0.01% 1270
2021
Q3 		$4K Buy
+51
New +$3.94K ﹤0.01% 1417
2020
Q4 		– Sell
-1,250
Closed -$74K – 1503
2020
Q3 		$74K Buy
1,250
+1,037
+487% +$70.8K 0.01% 787
2020
Q2 		$14K Buy
213
+199
+1,421% +$12.6K ﹤0.01% 882
2020
Q1 		$0 Sell
14
-1,116
-99% -$63.3K ﹤0.01% 1157
2019
Q4 		$73K Sell
1,130
-1,190
-51% -$79.5K 0.01% 889
2019
Q3 		$144K Buy
+2,320
New +$146K 0.01% 754
2019
Q2 		– Sell
-160
Closed -$12K – 1327
2019
Q1 		$12K Sell
160
-3,266
-95% -$247K ﹤0.01% 929
2018
Q4 		$289K Buy
+3,426
New +$365K 0.03% 566
2017
Q2 		– Sell
-672
Closed -$44K – 1246
2017
Q1 		$44K Buy
+672
New +$44.2K ﹤0.01% 932
2016
Q4 		– Sell
-7,343
Closed -$467K – 1214
2016
Q3 		$467K Buy
+7,343
New +$539K 0.05% 378
2015
Q3 		– Sell
-321
Closed -$20K – 1320
2015
Q2 		$20K Buy
+321
New +$17.5K ﹤0.01% 940
2015
Q1 		– Sell
-1,521
Closed -$50K – 1219
2014
Q4 		$50K Buy
+1,521
New +$49.5K 0.02% 827
2014
Q2 		– Sell
-1,763
Closed -$73K – 1287
2014
Q1 		$73K Buy
1,763
+1,603
+1,002% +$66.8K 0.02% 681
2013
Q4 		$5K Buy
+160
New +$5.21K ﹤0.01% 924

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Quantbot Technologies's LGND Position: Q1 2026 in Review

Quantbot Technologies sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 4,644 shares — an estimated $878K sold.

Quantbot Technologies first reported a position in LGND in Q4 2013 and held it in 17 quarters. The position peaked at $878K in Q4 2025. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Quantbot Technologies reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 4,644 Ligand Pharmaceuticals shares in Q1 2026, an estimated $878K.
  • Quantbot Technologies first reported a position in Ligand Pharmaceuticals in Q4 2013 and held it in 17 quarters.
  • Quantbot Technologies's Ligand Pharmaceuticals position peaked at $878K in Q4 2025.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.